Newsroom
OIG Recommendations Could Have Saved $24 Billion
The failure of federal agencies to implement 25 sets of "significant" recommendations from the HHS Office of Inspector General has cost US taxpayers and beneficiaries some $24 billion.
Using Big Data to Understand High Costs in Healthcare
Buried deep within large datasets are answers to long-standing questions about healthcare in the United States: Why is it so expensive? Why do prices vary so widely across the country?
The Downsides to Healthcare Price Transparency
Last year, more than half of working Americans reportedly checked prices for the health services they required. Healthcare providers and policy makers are scrambling to meet consumer demand for accurate pricing, and it’s not easy.
Managed Care Minute: March 28, 2015
A one-minute look at managed care news during the week of March 23, 2015, including the 5-year anniversary of the Affordable Care Act and another step toward value-based payments.
Voters Prefer Federal Exchange to State-Run Ones
Although the Supreme Court’s decision on King v. Burwell could remove subsidies from the federal marketplace, Americans prefer HealthCare.gov over the state-run exchanges, according to poll results from right-wing advocacy group Foundation for Government Accountability.
Hypertension Deaths Up, CDC Finds
The overall death rate from high blood pressure in the United States has increased 23% since 2000, even as the death rate from all other causes has dropped 21%, health officials reported.
The Argument for More Thoughtful Health IT Use
Technological innovations in medicine can help treat illness and improve health, but they also drive healthcare spending higher.
Aledade Puts Tools for Success in the Hands of Physician-Led ACOs
When Aledade launched in 2014, founder Farzad Mostashari, MD, former national coordinator for health information technology (IT), was spending about half the time talking to doctors not about his new company, but about value-based payments and what accountable care organizations were.
Primary Care Support Reduced Admissions, ED Visits
Speaking to an audience of national quality measurement experts, CMS's chief medical officer spotlights projects that have bolstered both the pace of cost reduction and quality improvement efforts.
Newt Gingrich Discusses the Presumption of Change in Healthcare
During his closing keynote at the World Health Care Congress, former Speaker of the House Newt Gingrich echoed the sessions of the previous 3 days by discussing current and future change in healthcare.
Why Pharma Is Investing in Rare Diseases
As patents on some of the most lucrative medicines began to expire, many companies shifted money to rare-disease drugs, knowing that those medicines cost less to develop and will face limited competition.
Creating a Global Cancer Resource
The Global Cancer Project Map is an interactive online database that allows users to search for cancer experts and research projects by country and by cancer type, and then to initiate contact with project principal investigators and program directors.
Medical Loss Ratio Provision Pays Consumers $5 Billion From 2011-2013
The adoption of the Affordable Care Act’s medical loss ratio provision, which requires insurers spend 80%-85% of premiums on medical care and quality improvement, has yielded large benefits for consumers from 2011 to 2013.
Survey Identifies Gaps in Communication and Decision Tools in Breast Cancer Survivors
The study, published in The Journal of Community and Supportive Oncology, discovered cancer survivors perceive gaps in their care with respect to reviewing information, asking questions, obtaining answers, and making decisions.
San Francisco Close to Implementing Drug Take-Back Program
San Francisco has taken a big step toward becoming the first major US city to require drug makers to fund and administer a citywide take-back program in which consumers can bring unused and unexpired medicines to drop-off destinations for disposal.
Thiazolidinediones Stimulate the Brain of T2DM Patients to Eat More, Study Finds
The study found that thiazolidinediones, commonly used to treat individuals suffering from type 2 diabetes, activate the PPARY' receptors in the hypothalamus, which in turn triggers food hoarding, food intake.
Melanoma Trial Halted Early; Keytruda Betters Yervoy
Currently, Keytruda is approved for patients with advanced melanoma previously treated with Yervoy and, in some patients, another type of drug as well. That second- and third-line status limits the number of patients eligible for the drug.
Driving Precision Medicine With Exceptional Responders
The NCI wants to encourage clinical trial investigators to review data from their completed clinical trials and treating oncologists to look back in their patient records to identify potential cases of exceptional responses and submit them for consideration in the initiative.
HHS Launches Public-Private Effort to Accelerate Healthcare Transformation
The Health Care Payment Learning and Action Network kicked off with its inaugural meeting bringing together public and private sector actors to discuss efforts to move healthcare toward a system that pays based on quality rather than quantity.
FDA Approves Eylea to Treat Diabetic Retinopathy in Patients With Diabetic Macular Edema
Diabetic retinopathy affects 33% of all patients with diabetes over 40; 29 million Americans have type 1 or type 2 diabetes.
Health Plan Cancellations Remain Uncommon Despite Concerns
With the Affordable Care Act’s requirement that most nongroup health insurance plans offer minimum coverage standards, concerns arose about plan cancellations affecting those who already had insurance coverage. However, recent data found cancellations were uncommon.
Diabetes Raises Risk of Developing Advanced Stage Breast Cancer, Study Finds
Diabetes is associated with more advanced stage breast cancer, according to a new study that confirms a strong link between diabetes and later stage breast cancer at diagnosis.
Nivolumab Effective in Peviously Treated RCC Patients
The authors however cautioned that we still lack an understanding of biomarker-driven patient selection for PD-1 and PD-L1 agent. Adequate knowledge of the mechanism of action of these immuno-oncology agents could help optimize therapy, they add.
Telehealth Palliative Care Model Reports Benefits in Cancer Patients
The ENABLE trial, conducted in rural regions of Vermont and New Hampshire, reports a positive impact on the 1-year survival of advanced cancer patients. A parallel study, ENABLE III, reported benefits to caregivers following early introduction of palliative care in these advanced cancer patients.
Provenge On Its Way to Gain Approval in Germany
Dendreon's prostate cancer immunotherapy Provenge is now being backed by IQWiG just months after the German health technology assessor was poised to reject the treatment.